| n (%)* | Univariate OR (95% CI ) | P value | Multivariate OR (95% CI) | P value |
---|---|---|---|---|---|
Age at HIV clinic registration (per year older) | n = 532 | 0.99 (0.97-1.01) | 0.308 | - | - |
Gender-ethnicity risk group | n = 515 | Â | Â | Â | Â |
   White MSM | 106 (20.6 | 1.00 (REF) |  | 1.00 (REF) |  |
   Black African/Caribbean MSM | 25 (4.9%) | 0.61 (0.23-1.67) | 0.340 | 0.58 (0.17-1.94) | 0.373 |
   Black African heterosexual female | 158 (30.7%) | 1.67 (1.00-2.78) | 0.048 | 1.57 (0.82-2.98) | 0.172 |
   Black African heterosexual male | 66 (12.8%) | 4.17 (2.17-8.03) | < 0.001 | 3.91 (1.77-8.64) | 0.001 |
   Black Caribbean heterosexual female | 30 (5.8%) | 1.13 (0.48-2.62) | 0.783 | 1.47 (0.55-3.90) | 0.442 |
   Black Caribbean heterosexual male | 20 (3.9%) | 2.38 (0.90-6.26) | 0.080 | 2.16 (0.67-7.01) | 0.199 |
   White heterosexual female | 16 (3.1%) | 0.88 (0.29-2.74) | 0.831 | 0.46 (0.09-2.38) | 0.356 |
   White heterosexual male | 12 (2.3%) | 0.65 (0.17-2.54) | 0.534 | 1.91 (0.36-10.12) | 0.448 |
   Other | 82 (15.9%) | 1.68 (0.93-3.03) | 0.086 | 1.48 (0.69-3.20) | 0.318 |
Year of KCH HIV clinic registration | n = 532 | 0.78 (0.74-0.84) | < 0.001 | 0.75 (0.68-0.83) | < 0.001 |
   2003-2005 | 255 | 1.00 (REF) |  | 1.00 (REF) |  |
   2000-2002 | 191 | 2.77 (1.88-4.09) | < 0.001 | 2.91 (1.77-4.78) | < 0.001 |
   1997-1999 | 86 | 4.70 (2.78-7.94) | < 0.001 | 5.26 (2.71-10.19) | < 0.001 |
CDC stage prior to LFU Ç‚ | n = 495 | Â | Â | Â | Â |
   AIDS | 31 (6.3%) | 1.00 (REF) |  | 1.00 (REF) |  |
   Symptomatic | 131 (26.5%) | 0.40 (0.18-0.89) | 0.025 | 0.83 (0.28-2.44) | 0.732 |
   Asymptomatic | 333 (67.3%) | 0.64 (0.30-1.33) | 0.229 | 1.51 (0.52-4.41) | 0.446 |
CD4 cell count prior to LFU Ç‚ , cells/mm 3 | n = 456 | Â | Â | Â | Â |
   > 350 | 306 (67.1%) | 1.00 (REF) |  | 1.00 (REF) |  |
   200-350 | 103 (22.6%) | 1.03 (0.65-1.64) | 0.908 | 0.98 (0.58-2.44) | 0.941 |
   < 200 | 47 (10.3%) | 3.55 (1.86-6.79) | < 0.001 | 3.24 (1.49-7.04) | 0.003 |